June 5, 2019 --The American Thoracic Society is concerned by today’s announcement of the Trump Administration’s restrictions on federal support for fetal tissue research.
ATS Research Advocacy Committee Chair Veena Antony, MD, said, “The ATS is very disturbed by the administration’s actions to halt certain NIH scientific research using fetal tissue. Scientific research using fetal tissue is vital for the development of new treatments for many deadly diseases and conditions such as cystic fibrosis and acute lung injury. There are no alternative research models that can replace all fetal tissue research.”
Dr. Antony added, “The ATS urges the Administration to restore federal funding for fetal tissue research across all agencies, including all intramural and extramural research, so that these efforts to develop life-saving treatments and cures can continue.”
